medline.ch Dermatologie Psoriasis

	Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BEÂ SURE, BEÂ VIVID, BEÂ READY, and BEÂ BRIGHT. Dermatol Ther (Heidelb) Armstrong A, Papp KA, Lebwohl M, Savage LJ, Yamanaka K, Vlase DE, Warham R, Lambert J, López Pinto JM, Wixted K, Thaçi D. PMID: 41359217 [PubMed - as supplied by publisher]
	Impact of concomitant fibromyalgia on patient-reported outcomes and inflammatory markers in psoriatic arthritis: a multinational cross-sectional study. Rheumatol Int Maroof A, Ziadé N, Abbas N, Gossec L, Kibbi LE, Elzorkany B, Jassim NA, Gorial FI, Adnan A, Al Shamaa N, Haouichat C, Alnaimat F, Hannawi S, Atawnah S, Saad SA, Halabi H, Aljazwi L, Masri BK, Abogamal A, Ayoub L, Rachid B, Aouad K, Hmamouchi I, Al Mashaleh M. PMID: 41359126 [PubMed - in process]
	Characterization of Ferroptosis-Associated Subtypes in Psoriasis and the Potential of CHAC1 as a Diagnostic Biomarker Based on Machine Learning. Clin Cosmet Investig Dermatol Chen J, Zhan J, Zhou Y. PMID: 41357319 [PubMed]
	Case Report: Exploring the underlying mechanisms of psoriasis comorbid with sarcoidosis: insights from a case of coexisting immune-related disorders. Front Immunol Zhen Y, Liang X, Huang D, Ding Y, Shi Y, Yu Q. PMID: 41357198 [PubMed - indexed for MEDLINE]
	The complex interplay between psoriasis and depression: from molecular mechanisms to holistic treatment approaches. Front Immunol Wang Y, Xing J, Liang Y, Liang H, Niu X, Li J, Zhang K. PMID: 41357183 [PubMed - indexed for MEDLINE]
	PEGylated Peptide for Targeted Inhibition of Human Antigen R as a Novel Therapeutic Strategy for Psoriasis: A Proof-of-Concept Study. Psoriasis (Auckl) Chen YF, Jiang YS, Chen YC, Chang CH, Jan JS. PMID: 41356271 [PubMed]
	Lipoprotein (a) levels are elevated in psoriasis: An updated systematic review and meta-analysis. World J Clin Cases Fragkouli MR, Makris A, Mastori-Kourmpani C, Karpettas N, Hadjigeorgiou GF, Tsioutis C, Filippatos TD, Agouridis AP. PMID: 41356092 [PubMed]
	Discontinuing or Tapering Biologic or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: A Systematic Literature Review. Int J Rheum Dis Aw NMY, Fong W, Shin K, Angkodjojo S, Leung YY. PMID: 41355344 [PubMed - indexed for MEDLINE]
	Efficacy of 450-nm blue laser-mediated aminolevulinic acid photodynamic therapy for plaque psoriasis: a prospective self-controlled clinical trial. Lasers Med Sci Tuo H, Fan H, Sun Y, Yang Y, Ju M, Xie Y, Wang Y, He D, Zheng Y. PMID: 41354718 [PubMed - indexed for MEDLINE]
	Comparison between RoB-1 and RoB-2 tool and impact on network meta-analysis results - a case study from a living Cochrane review on psoriasis. J Clin Epidemiol Guelimi R, Choudhary C, Ollivier C, Beytout Q, Samaran Q, Mubuangankusu A, Chaimani A, Sbidian E, Afach S, Le Cleach L. PMID: 41352579 [PubMed - as supplied by publisher]
	Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis. Dermatol Ther (Heidelb) Armstrong AW, Warren RB, Sofen H, Spelman L, Linaberry M, Becker B, Jou YM, Daamen C, Kimball AB. PMID: 41350512 [PubMed - as supplied by publisher]
	Single cell mapping identifies a distinct platelet-phenotype in psoriatic type III inflammation. Nat Commun Kommoss KS, Krishnarajah S, Bieler T, Friebel E, Rindlisbacher L, Ramadori P, Häne P, Kam S, Müller F, Prokosch S, Rothermel U, Wu Y, Barletta F, Czemmel S, Nahnsen S, Helm D, Schneider M, Schäkel K, Enk A, Becher B, Heikenwälder M. PMID: 41350257 [PubMed - indexed for MEDLINE]
	Comparative effectiveness of ixekizumab versus ustekinumab in patients with psoriasis: an RCT replication using data from an observational study (SPEECH). Value Health Yu N, Cui L, Wang Y, Wang Y, Song X, Yang Q, Shi Y. PMID: 41349837 [PubMed - as supplied by publisher]
	Evaluation of the risk of psoriatic arthritis in patients with psoriasis undergoing biological treatment. Global population study (TRINETX). Actas Dermosifiliogr Rivera-Diaz R, Joven B, Hernandez-Ibarburu G, García-Donoso C, Pablos JL, Ortiz-Romero PL. PMID: 41349679 [PubMed - as supplied by publisher]
	Influence of Metabolic Factor Control on Psoriatic Arthritis Risk in Psoriasis Patients: A Retrospective Cohort Study Using TriNetX Database. Mayo Clin Proc Shen YH, Huang YC. PMID: 41348069 [PubMed - as supplied by publisher]
	Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study. Australas J Dermatol Díaz JM, Alarcón SS, Romero IB, Apetrei LS, Fernández LG, Ramos FJM, Alberola FT, Martínez MAB, Ruiz AB, Rodríguez OB, Ruiz-Villaverde R, González MC, Farrés MF, Puchades AM, Tapial JM, Rull EV, Montalvo SM. PMID: 41347368 [PubMed - as supplied by publisher]
	Case Report: Acute generalized exanthematous pustulosis with psoriasis successfully treated with Secukinumab. Front Immunol Zheng JN, Liu X, Shi Y, Gu J, Gong Y. PMID: 41346610 [PubMed - indexed for MEDLINE]
	Dermoscopic Evaluation of Scalp Psoriasis and its Relation with Disease Severity: A Cross-sectional Study from South India. Int J Trichology Parvathy M, Ajayakumar S, Pretty M, Anoop T, Sridharan R. PMID: 41346551 [PubMed]
	Laboratory monitoring in patients with moderate to severe plaque psoriasis. J Dermatolog Treat Fenkel JM, Osborne JA, Armstrong AW, Strober B, Stein Gold L, Cameron M, Lebwohl M. PMID: 41346021 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Biologics in the Treatment of Pediatric Psoriatic Arthritis: A Systematic Review. J Cutan Med Surg Peri K, Fajardo RG, Lansang RP, Lansang P. PMID: 41346010 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 27138

Seite 1 von 1357

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung